Mitochondrial cytopathy in adults: What we know so far

被引:55
作者
Cohen, BH [1 ]
Gold, DR [1 ]
机构
[1] Cleveland Clin Fdn, Dept Neurol, Sect Pediat Neurol, Cleveland, OH 44195 USA
关键词
D O I
10.3949/ccjm.68.7.625
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mitochondrial cytopathies are a diverse group of inherited and acquired disorders that result in inadequate energy production. They can be caused by inheritable genetic mutations, acquired somatic mutations, exposure to toxins (including some prescription medications), and the aging process itself. In addition, a number of well-described diseases can decrease mitochondrial energy production; these include hyperthyroidism, hypothyroidism, and hyperlipidemia.
引用
收藏
页码:625 / +
页数:20
相关论文
共 61 条
[1]   MARKED REDUCTION IN CSF LACTATE AND PYRUVATE LEVELS AFTER COQ THERAPY IN A PATIENT WITH MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC-ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) [J].
ABE, K ;
FUJIMURA, H ;
NISHIKAWA, Y ;
YORIFUJI, S ;
MEZAKI, T ;
HIRONO, N ;
NISHITANI, N ;
KAMEYAMA, M .
ACTA NEUROLOGICA SCANDINAVICA, 1991, 83 (06) :356-359
[2]   Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA [J].
Andreu, AL ;
Hanna, MG ;
Reichmann, H ;
Bruno, C ;
Penn, AS ;
Tanji, K ;
Pallotti, F ;
Iwata, S ;
Bonilla, E ;
Lach, B ;
Morgan-Hughes, J ;
DiMauro, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) :1037-1044
[3]   Improved brain and muscle mitochondrial respiration with CoQ.: An in vivo study by 31P-MR spectroscopy in patients with mitochondrial cytopathies [J].
Barbiroli, B ;
Iotti, S ;
Lodi, R .
BIOFACTORS, 1999, 9 (2-4) :253-260
[4]   MYOINTESTINAL, NEUROINTESTINAL, GASTROINTESTINAL ENCEPHALOPATHY (MNGIE SYNDROME) DUE TO PARTIAL DEFICIENCY OF CYTOCHROME-C-OXIDASE - A NEW MITOCHONDRIAL MULTISYSTEM DISORDER [J].
BARDOSI, A ;
CREUTZFELDT, W ;
DIMAURO, S ;
FELGENHAUER, K ;
FRIEDE, RL ;
GOEBEL, HH ;
KOHLSCHUTTER, A ;
MAYER, G ;
RAHLF, G ;
SERVIDEI, S ;
VANLESSEN, G ;
WETTERLING, T .
ACTA NEUROPATHOLOGICA, 1987, 74 (03) :248-258
[5]   DOES IMPAIRMENT OF ENERGY-METABOLISM RESULT IN EXCITOTOXIC NEURONAL DEATH IN NEURODEGENERATIVE ILLNESSES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1992, 31 (02) :119-130
[6]   P-31 NMR-SPECTROSCOPY AND ERGOMETER EXERCISE TEST AS EVIDENCE FOR MUSCLE OXIDATIVE PERFORMANCE IMPROVEMENT WITH COENZYME-Q IN MITOCHONDRIAL MYOPATHIES [J].
BENDAHAN, D ;
DESNUELLE, C ;
VANUXEM, D ;
CONFORTGOUNY, S ;
FIGARELLABRANGER, D ;
PELLISSIER, JF ;
KOZAKRIBBENS, G ;
POUGET, J ;
SERRATRICE, G ;
COZZONE, PJ .
NEUROLOGY, 1992, 42 (06) :1203-1208
[7]   UBIDECARENONE IN THE TREATMENT OF MITOCHONDRIAL MYOPATHIES - A MULTICENTER DOUBLE-BLIND TRIAL [J].
BRESOLIN, N ;
DORIGUZZI, C ;
PONZETTO, C ;
ANGELINI, C ;
MORONI, I ;
CASTELLI, E ;
COSSUTTA, E ;
BINDA, A ;
GALLANTI, A ;
GABELLINI, S ;
PICCOLO, G ;
MARTINUZZI, A ;
CIAFALONI, E ;
ARNAUDO, E ;
LICIARDELLO, L ;
CARENZI, A ;
SCARLATO, G .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1990, 100 (1-2) :70-78
[8]   CLINICAL AND BIOCHEMICAL CORRELATIONS IN MITOCHONDRIAL MYOPATHIES TREATED WITH COENZYME-Q10 [J].
BRESOLIN, N ;
BET, L ;
BINDA, A ;
MOGGIO, M ;
COMI, G ;
NADOR, F ;
FERRANTE, C ;
CARENZI, A ;
SCARLATO, G .
NEUROLOGY, 1988, 38 (06) :892-899
[9]   PLASMA CARNITINE INSUFFICIENCY AND EFFECTIVENESS OF L-CARNITINE THERAPY IN PATIENTS WITH MITOCHONDRIAL MYOPATHY [J].
CAMPOS, Y ;
HUERTAS, R ;
LORENZO, G ;
BAUTISTA, J ;
GUTIERREZ, E ;
APARICIO, M ;
ALESSO, L ;
ARENAS, J .
MUSCLE & NERVE, 1993, 16 (02) :150-153
[10]   Clinical, biochemical and molecular genetic features of Leber's hereditary optic neuropathy [J].
Chalmers, RM ;
Schapira, AHV .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1410 (02) :147-158